Drug recall
Subutex (buprenorphine), 2 mg, 30 sublingual tablet, Rx only, Manufactured and distributed by Reckitt…
FDA recall event 29882 · Class II · Reckitt Benckiser Pharmaceut Inc
Key facts
| Event ID | 29882 |
|---|---|
| Recall numbers | D-273-4 |
| Recalling firm | Reckitt Benckiser Pharmaceut Inc |
| Product type | Drugs |
| Products | Subutex (buprenorphine), 2 mg, 30 sublingual tablet, Rx only, Manufactured and distributed by Reckitt Benckiser Pharmaceuticals, Inc., NDC 12496-1278-2. |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Mispackaging: Subutex 2 mg bottles contain Subutex 8 mg tablets |
| Initiation date | Aug 23, 2004 |
| City | Richmond |
| Country | United States |
| FEI number | 1000209845 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports